Omnicell, Inc. (OMCL)
NASDAQ: OMCL · Real-Time Price · USD
39.25
-2.05 (-4.98%)
Mar 9, 2026, 2:49 PM EDT - Market open

Company Description

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally.

It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process.

The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services.

In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform.

The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001.

Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Omnicell, Inc.
Omnicell logo
Country United States
Founded 1992
IPO Date Aug 7, 2001
Industry Health Information Services
Sector Healthcare
Employees 3,580
CEO Randall Lipps

Contact Details

Address:
4220 North Freeway
Fort Worth, Texas 76137
United States
Phone 877 415 9990
Website omnicell.com

Stock Details

Ticker Symbol OMCL
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000926326
CUSIP Number 68213N109
ISIN Number US68213N1090
Employer ID 94-3166458
SIC Code 3571

Key Executives

Name Position
Randall A. Lipps Founder, Executive Chairman, President and Chief Executive Officer
Nnamdi N. Njoku Executive Vice President and Chief Operating Officer
Corey J. Manley J.D. Executive Vice President, Chief Legal and Administrative Officer and Corporate Secretary
Brian H. Nutt Vice President, Chief Accounting Officer and Corporate Controller
Dr. Perry A. Genova Ph.D. Senior Vice President and Chief Technology Officer
Kathleen Nemeth Senior Vice President of Investor Relations
Tomer Stavitsky Senior Vice President and Chief Corporate Development Officer
Stella Prefach Senior Vice President and Chief Marketing Officer
Dave Ford SVice President and Chief People Officer

Latest SEC Filings

Date Type Title
Feb 26, 2026 10-K Annual Report
Feb 17, 2026 144 Filing
Feb 5, 2026 8-K Current Report
Jan 8, 2026 144 Filing
Dec 16, 2025 144 Filing
Dec 8, 2025 8-K Current Report
Dec 3, 2025 144 Filing
Dec 1, 2025 144 Filing
Nov 17, 2025 144 Filing
Nov 5, 2025 10-Q Quarterly Report